We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

81 hedge funds and large institutions have $396M invested in Aratana Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,500% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 1

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

76% more funds holding

Funds holding: 4681 (+35)

73% more capital invested

Capital invested by funds: $229M → $396M (+$167M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
81
Holders Change
+35
Holders Change %
+76.09%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
36
Increased
31
Reduced
9
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Teacher Retirement System of Texas
76
Teacher Retirement System of Texas
Texas
$13K +$10.3K +513 +249%
SO
77
STRS Ohio
Ohio
$7K
Barclays
78
Barclays
United Kingdom
$6K -$15.6K -779 -70%
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$620 +$761 +38 +543%
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$108 +$11.2K +557 +11%
BAMCO Inc
81
BAMCO Inc
New York
-$121K -6,360 Closed
PTC
82
Private Trust Company
Ohio
+$421 +21 New

PETX Hedge Fund Activity: Q1 2014 in Review

81 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q1 2014, worth a combined $396M — up 73% from $229M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new PETX positions and 1 closed out — a net gain of 35 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was Franklin Resources, adding an estimated $31.4M. The largest seller was MPM Asset Management, cutting an estimated $31.3M.

  • 81 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q1 2014, up from 46 in Q4 2013.
  • Funds reported $396M of Aratana Therapeutics, Inc. stock for Q1 2014, up 73% quarter-over-quarter.
  • 36 funds opened new Aratana Therapeutics, Inc. positions in Q1 2014 and 1 closed out, a net change of +35 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q1 2014 was Franklin Resources, an estimated $31.4M added.
  • The largest Aratana Therapeutics, Inc. seller in Q1 2014 was MPM Asset Management, an estimated $31.3M sold.

Based on aggregated 13F filings for Q1 2014.